← Back to headlines
CVS Transforms Pharmacies for GLP-1 Drug Delivery, Analyst Recommends Stock Buy
CVS has converted its 9,000 pharmacies into a delivery system for GLP-1 drugs, leading a top Wall Street analyst to recommend buying the company's stock.
27 Jun, 04:50 — 27 Jun, 04:50
Sources
Showing 1 of 1 sources
Related Stories
Recent Corporate Earnings Releases Highlight Divergent Financial Performance
26m ago
Markets Brace for Nvidia Earnings and Key PCE Inflation Data
27m ago
OpenAI’s Head of Data Centers Chris Malone Departs the Company
28m ago
Enbridge Acquires Salt Creek Midstream Crude Gathering Assets for $600 Million
34m ago